For years, malaria has ruled mercilessly in certain regions of the world. Especially in Africa. Yet over the past decade, despite the absence of a malaria vaccine, one anti-malarial strategy sought to make a difference: more than 700 million doses of Seasonal Malaria Chemoprevention (SMC) were distributed to young children, globally.
The evidence is now clear: SMC has helped to save hundreds of thousands of their lives. So much so, that more countries have now begun to implement SMC, which involves the intermittent administration of a curative dose of antimalarial medicine to children at high risk of severe malaria living in areas with seasonal transmission, regardless of whether they are infected with malaria.
Read the full op-ed on the Health Policy Watch website.